Skip to main content
Premium Trial:

Request an Annual Quote

Princess Margaret Personalized Medicine Effort Reaps $50M Gift

NEW YORK (GenomeWeb News) – Canada's Princess Margaret Cancer Foundation said today that it will use a new C$50 million (US$50.3 million) private donation to fund a research effort that will use genomics, molecular imaging, and tumor biology studies to develop personalized cancer medicine innovations.

The gift from philanthropists Emmanuelle Gattuso and Allan Slaight will fund the Princess Margaret Cancer Centre's Personalized Cancer Medicine Initiative. The cancer center's research arm is the Ontario Cancer Institute, which includes the Campbell Family Cancer Research Institute.

The new donation will support the foundation's Billion Dollar Challenge, which aims to raise C$1 billion to fund the personalized medicine effort and has netted C$243 million in donations and grants to date.

The Personalized Cancer Medicine Initiative will fund research projects seeking to detect tumors earlier in their progression, analyze them more precisely, and target them with specific interventions.

"This unprecedented "superfund" allows us to build and support research teams focused on precision genomics, advanced tumour biology, immune therapy, and molecular imaging," Benjamin Neel, research director of the Princess Margaret Cancer Centre, said in a statement.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.